1 – 10 of 89
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
evoke and evoke+ : design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease
Cummings, Jeffrey L. ; Atri, Alireza ; Feldman, Howard H. ; Hansson, Oskar LU
; Sano, Mary
; Knop, Filip K.
; Johannsen, Peter
; León, Teresa
and Scheltens, Philip
(2025)
In Alzheimer's Research and Therapy
17(1).
- Contribution to journal › Article
-
Mark
Benchmarking Alzheimer’s disease prediction : personalised risk assessment using polygenic risk scores across various methodologies and genome-wide studies
Bellou, Eftychia ; Kim, Woori ; Leonenko, Ganna ; Tao, Feifei ; Simmonds, Emily ; Wu, Ying ; Mattsson-Carlgren, Niklas LU
; Hansson, Oskar
LU
; Nagle, Michael W.
and Escott-Price, Valentina
(2025)
In Alzheimer's Research and Therapy
17(1).
- Contribution to journal › Article
-
Mark
TREM2 risk variants and associated endophenotypes in alzheimer’s disease
- Contribution to journal › Article
-
Mark
Differential effects of aging, Alzheimer's pathology, and APOE4 on longitudinal functional connectivity and episodic memory in older adults
- Contribution to journal › Article
-
Mark
Neuronal CD59 isoforms IRIS-1 and IRIS-2 as regulators of neurotransmitter release with implications for Alzheimer’s disease
Golec, Ewelina LU ; Olsson, Robin LU
; Tuysuz, Emre Can
LU
; Karlsson, Maja
LU
; Serjieh, Yasmin
LU
; King, Ben C.
LU
; Wennström, Malin
LU
and Blom, Anna M.
LU
(2025)
In Alzheimer's Research and Therapy
17(1).
- Contribution to journal › Article
- 2024
-
Mark
Rationale and design of the BeyeOMARKER study : prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer’s disease pathology in the eye clinic
- Contribution to journal › Article
-
Mark
The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer’s disease patients and App NL−F/NL−F mice
Nuñez-Diaz, Cristina LU ; Andersson, Emelie LU
; Schultz, Nina
LU
; Pocevičiūtė, Dovilė
LU
; Hansson, Oskar
LU
; Nilsson, K. Peter R.
and Wennström, Malin
LU
(2024)
In Alzheimer's Research and Therapy
16(1).
- Contribution to journal › Article
-
Mark
Relationships of change in Clinical Dementia Rating (CDR) on patient outcomes and probability of progression : observational analysis
Tariot, Pierre N. ; Boada, Mercè ; Lanctôt, Krista L. ; Hahn-Pedersen, Julie ; Dabbous, Firas ; Udayachalerm, Sariya ; Raket, Lars Lau LU
; Halchenko, Yuliya
; Michalak, Wojciech
and Weidner, Wendy
, et al.
(2024)
In Alzheimer's Research and Therapy
16(1).
- Contribution to journal › Article
-
Mark
Comparing a pre-defined versus deep learning approach for extracting brain atrophy patterns to predict cognitive decline due to Alzheimer’s disease in patients with mild cognitive symptoms
Arvidsson, Ida LU
; Strandberg, Olof
LU
; Palmqvist, Sebastian
LU
; Stomrud, Erik
LU
; Cullen, Nicholas
LU
; Janelidze, Shorena
LU
; Tideman, Pontus
LU
; Heyden, Anders
LU
; Åström, Karl
LU
and Hansson, Oskar
LU
, et al.
(2024)
In Alzheimer's Research and Therapy
16(1).
- Contribution to journal › Article
-
Mark
Biological mechanisms of resilience to tau pathology in Alzheimer’s disease
Svenningsson, Anna L. LU
; Bocancea, Diana I.
LU
; Stomrud, Erik
LU
; van Loenhoud, Anita
; Barkhof, Frederik
; Mattsson-Carlgren, Niklas
LU
; Palmqvist, Sebastian
LU
; Hansson, Oskar
LU
and Ossenkoppele, Rik
LU
(2024)
In Alzheimer's Research and Therapy
16(1).
- Contribution to journal › Article